CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection
MS Pampusch, HM Abdelaal, EK Cartwright… - PLoS …, 2022 - journals.plos.org
During chronic human immunodeficiency virus (HIV) or simian immunodeficiency virus (SIV)
infection prior to AIDS progression, the vast majority of viral replication is concentrated within …
infection prior to AIDS progression, the vast majority of viral replication is concentrated within …
Simian immunodeficiency virus (SIV)-specific chimeric antigen receptor-T cells engineered to target B cell follicles and suppress SIV replication
KP Haran, A Hajduczki, MS Pampusch… - Frontiers in …, 2018 - frontiersin.org
There is a need to develop improved methods to treat and potentially cure HIV infection.
During chronic HIV infection, replication is concentrated within T follicular helper cells (Tfh) …
During chronic HIV infection, replication is concentrated within T follicular helper cells (Tfh) …
Simple and efficient methods for enrichment and isolation of endonuclease modified cells
BS Moriarity, EP Rahrmann, DA Beckmann… - PloS one, 2014 - journals.plos.org
The advent of Transcription Activator-Like Effector Nucleases (TALENs), and similar
technologies such as CRISPR, provide a straightforward and cost effective option for …
technologies such as CRISPR, provide a straightforward and cost effective option for …
Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer
M Multhaup, AD Karlen, DL Swanson, A Wilber… - Human gene …, 2010 - liebertpub.com
Artemis is a hairpin-opening endonuclease involved in nonhomologous end-joining and V
(D) J recombination. Deficiency of Artemis results in radiation-sensitive severe combined …
(D) J recombination. Deficiency of Artemis results in radiation-sensitive severe combined …
Efficient enrichment of gene-modified primary T cells via CCR5-targeted integration of mutant dihydrofolate reductase
B Paul, GSR Ibarra, N Hubbard, T Einhaus… - … Therapy-Methods & …, 2018 - cell.com
Targeted gene therapy strategies utilizing homology-driven repair (HDR) allow for greater
control over transgene integration site, copy number, and expression—significant …
control over transgene integration site, copy number, and expression—significant …
Role of Transgene Regulation in Ex Vivo Lentiviral Correction of Artemis Deficiency
MM Multhaup, KM Podetz-Pedersen, AD Karlen… - Human gene …, 2015 - liebertpub.com
Artemis is a single-stranded endonuclease, deficiency of which results in a radiation-
sensitive form of severe combined immunodeficiency (SCID-A) most effectively treated by …
sensitive form of severe combined immunodeficiency (SCID-A) most effectively treated by …
Characterization of the Human Artemis Promoter by Heterologous Gene Expression In Vitro and In Vivo
MM Multhaup, S Gurram, KM Podetz-Pedersen… - DNA and Cell …, 2011 - liebertpub.com
Artemis is an endonucleolytic enzyme involved in nonhomologous double-strand break
repair and V (D) J recombination. Deficiency of Artemis results in a B− T− radiosensitive …
repair and V (D) J recombination. Deficiency of Artemis results in a B− T− radiosensitive …
Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1)
S Brennig, N Lachmann, T Buchegger, M Hetzel… - Journal of Experimental …, 2015 - Springer
Background Hematologic toxicity represents a major side effect of cytotoxic chemotherapy
frequently preventing adequately dosed chemotherapy application and impeding …
frequently preventing adequately dosed chemotherapy application and impeding …
Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells
JP Volpato, N Mayotte, E Fossati… - Journal of Molecular …, 2011 - Wiley Online Library
Ex vivo selection of transduced hematopoietic stem cells (HSC) with drug‐resistance genes
offers the possibility to enrich transduced cells prior to engraftment, toward increased …
offers the possibility to enrich transduced cells prior to engraftment, toward increased …
In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase
JL Gori, X Tian, D Swanson, R Gunther, LD Shultz… - Gene therapy, 2010 - nature.com
Human embryonic stem cells (hESCs) provide a novel source of hematopoietic and other
cell populations suitable for gene therapy applications. Preclinical studies to evaluate …
cell populations suitable for gene therapy applications. Preclinical studies to evaluate …